The Value of Vision
The case for investing in eye health in
China
The Value of Vision: The case for investing in eye health in
China
-
- No results
Investing $1.34 billion USD in eye health in
China over 2026-2030 will deliver $91.6 billion USD in economic benefits, as well as:
The benefits of investment
Good vision is foundational to economic and societal participation. Investment in eye care in China will lead to higher employment, improved productivity, better educational outcomes, reduced traffic accidents, and improved mental health and longevity.
Total economic benefit by 2030
Total other benefits by 2030
Economic benefits:
- Employment gains for individuals previously limited by sight loss and blindness
- Increased occupational productivity for those with mild or near sight loss actively employed
- Enhanced caregiver productivity freeing family members from caregiving responsibilities related to sight loss and blindness
- Improved educational outcomes for children whose vision is corrected, resulting in long-term increases in lifetime earnings
Selected filters
Social benefits over time
- Employment gains for individuals previously limited by sight loss and blindness
- Increased occupational productivity for those with mild or near sight loss actively employed
- Enhanced caregiver productivity freeing family members from caregiving responsibilities related to sight loss and blindness
- Improved educational outcomes for children whose vision is corrected, resulting in long-term increases in lifetime earnings
Selected filters
Sight loss averted by 2030
This investment in eye health would dramatically reduce the number of people with sight loss in China by 2030 and set the path for further declines by 2050.
The biggest early gains come from addressing presbyopia through cost-effective screening and ready-made near glasses, while reductions in distance vision loss will become increasingly important beyond 2030.
Selected filters
Accelerators in eye care needed in China
Our research has identified six key accelerator interventions which can help fight against sight loss and deliver huge productivity benefits back to countries by 2030
Select each accelerator intervention for more detail and recommended scale up over time.
Total investment required
Delivering the benefits outlined in this investment case will require an additional $1.34 billion USD over the next five years – beginning at $116 million USD in 2026 and scaling up to $357 million USD by 2030.
Selected filters
Accelerators in eye care needed in China
Here are the key actions for leaders worldwide to translate this investment case into reality.
Act
- Employment gains for individuals previously limited by sight loss and blindness
- Increased occupational productivity for those with mild or near sight loss actively employed
- Enhanced caregiver productivity freeing family members from caregiving responsibilities related to sight loss and blindness
- Improved educational outcomes for children whose vision is corrected, resulting in long-term increases in lifetime earnings
Allocate
- Employment gains for individuals previously limited by sight loss and blindness
- Increased occupational productivity for those with mild or near sight loss actively employed
- Enhanced caregiver productivity freeing family members from caregiving responsibilities related to sight loss and blindness
- Improved educational outcomes for children whose vision is corrected, resulting in long-term increases in lifetime earnings
Accelerate
- Employment gains for individuals previously limited by sight loss and blindness
- Increased occupational productivity for those with mild or near sight loss actively employed
- Enhanced caregiver productivity freeing family members from caregiving responsibilities related to sight loss and blindness
- Improved educational outcomes for children whose vision is corrected, resulting in long-term increases in lifetime earnings
Global investment case
Global investment case
The Value of Vision: The case for investing in eye health is available online.
We also provide detailed data and visualisations at both global and country levels, which can be explored on the IAPB Vision Atlas. Offering comprehensive insights to support evidence-based investment in eye health.
A report by